title: Purification and characterization of flavin-containing monooxygenase isoform 3 from rat kidney microsomes.
abstract: Rats are a common animal model for metabolism and toxicity studies. Previously, the enzymatic properties of rat flavin-containing monooxygenase (FMO) 1 purified from hepatic and renal microsomes and that of FMO3 purified from hepatic microsomes were characterized. This study investigated the physical, immunological, and enzymatic properties of FMO3 purified from male rat kidney microsomes and compared the results with those obtained with isolated rat liver FMO3. Renal FMO3 was purified via affinity columns based on the elution of L-methionine (Met) S-oxidase activity and reactivity of the eluted proteins with human FMO3 antibody. In general, Met S-oxidase-specific activity was increased 100-fold through the purification steps. The resulting protein had similar mobility (approximately 56 kDa) as isolated rat liver FMO3 and cDNA-expressed human FMO3 by SDS-polyacrylamide gel electrophoresis. When the isolated kidney protein band was subjected to trypsin digestion and matrix-assisted laser desorption ionization/time of flight mass spectral analysis, 34% of the sequence of rat FMO3 was detected. The apparent K(m) and V(max) values for rat kidney FMO3 were determined using the known FMO substrates Met, seleno-L-methionine, S-allyl-L-cysteine (SAC), and methimazole (N-methyl-2-mercaptoimidazole). The stereoselectivity of the reactions with Met and SAC were also examined using high-performance liquid chromatography. The obtained kinetic and stereoselectivity results were similar to those we obtained in the present study, or those previously reported, for rat liver FMO3. Taken together, the results demonstrate many similar properties between rat hepatic and renal FMO3 forms and suggest that renal FMO3 may play an important role in kidney metabolism of xenobiotics containing sulfur and selenium atoms.
authors.affiliation: Department of Comparative Biosciences and Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, Wisconsin 53706, USA.
authors.forename: Rachel M
authors.initials: RM
authors.lastname: Novick
authors.forename: Adnan A
authors.initials: AA
authors.lastname: Elfarra
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002384:Catalysis; D003545:Cysteine / Q000031:analogs & derivatives / Q000737:chemistry; D007668:Kidney / Q000737:chemistry*; D007700:Kinetics; D008297:Male; D008713:Methimazole / Q000737:chemistry; D008715:Methionine / Q000737:chemistry / Q000378:metabolism; D008861:Microsomes / Q000737:chemistry*; D008969:Molecular Sequence Data; D008970:Molecular Weight; D009249:NADP / Q000737:chemistry; D010105:Oxygenases / Q000737:chemistry* / Q000302:isolation & purification*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012645:Selenomethionine / Q000737:chemistry; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013237:Stereoisomerism
chemical_list: D009249:NADP; D008713:Methimazole; C065299:S-allylcysteine; D012645:Selenomethionine; D008715:Methionine; D010105:Oxygenases; C020066:dimethylaniline monooxygenase (N-oxide forming); D003545:Cysteine
references.citation: Drug Metab Dispos. 2002 Oct;30(10):1137-42
references.pmid: 12228191
references.citation: Drug Metab Dispos. 2002 Feb;30(2):119-28
references.pmid: 11792679
references.citation: Aquat Toxicol. 2006 Oct 12;79(4):401-9
references.pmid: 16935358
references.citation: J Biol Chem. 1994 May 13;269(19):14314-22
references.pmid: 8188717
references.citation: Am J Clin Nutr. 2003 May;77(5):1269-77
references.pmid: 12716682
references.citation: Mol Pharmacol. 2006 Jan;69(1):140-53
references.pmid: 16214954
references.citation: Metabolism. 2000 Aug;49(8):1071-7
references.pmid: 10954028
references.citation: Chem Res Toxicol. 1998 Oct;11(10):1145-53
references.pmid: 9778310
references.citation: Food Chem Toxicol. 2006 Mar;44(3):393-7
references.pmid: 16181716
references.citation: Mol Pharmacol. 1993 Mar;43(3):388-96
references.pmid: 8450833
references.citation: Drug Metab Dispos. 2000 Aug;28(8):930-6
references.pmid: 10901703
references.citation: Arch Biochem Biophys. 1994 Jan;308(1):254-7
references.pmid: 8311461
references.citation: J Pharm Pharmacol. 2006 May;58(5):617-23
references.pmid: 16640830
references.citation: Arch Biochem Biophys. 2001 Jul 1;391(1):30-40
references.pmid: 11414682
references.citation: Chem Res Toxicol. 2006 Dec;19(12):1643-9
references.pmid: 17173378
references.citation: Biochem J. 2007 Sep 15;406(3):491-9
references.pmid: 17547558
references.citation: Biochim Biophys Acta. 1993 Mar 5;1162(1-2):127-34
references.pmid: 8448176
references.citation: Mol Pharmacol. 1997 Mar;51(3):507-15
references.pmid: 9058607
references.citation: Drug Metab Dispos. 1996 Aug;24(8):891-8
references.pmid: 8869825
references.citation: Can J Physiol Pharmacol. 1994 Oct;72(10):1238-44
references.pmid: 7882190
references.citation: J Pharmacol Exp Ther. 1992 Jan;260(1):393-401
references.pmid: 1731048
references.citation: J Pharmacol Exp Ther. 2003 Jan;304(1):185-91
references.pmid: 12490590
references.citation: J Clin Invest. 1988 Feb;81(2):390-7
references.pmid: 3339126
references.citation: Pharmacogenetics. 2004 Feb;14(2):117-30
references.pmid: 15077013
references.citation: Pediatr Res. 2002 Feb;51(2):236-43
references.pmid: 11809920
references.citation: Biochem Pharmacol. 1991 Sep 12;42(7):1411-20
references.pmid: 1930264
references.citation: Drug Metab Dispos. 1999 Jan;27(1):46-52
references.pmid: 9884308
references.citation: Mol Pharmacol. 2003 Jan;63(1):253-61
references.pmid: 12488558
references.citation: Pharmacology. 2003 Mar;67(3):113-7
references.pmid: 12571405
references.citation: J Food Sci. 2007 Sep;72(7):S511-5
references.pmid: 17995665
references.citation: J Pharmacol Exp Ther. 2001 Dec;299(3):849-57
references.pmid: 11714868
references.citation: Annu Rev Pharmacol Toxicol. 2006;46:65-100
references.pmid: 16402899
references.citation: Arch Biochem Biophys. 1997 Jun 15;342(2):212-23
references.pmid: 9186481
references.citation: Arch Biochem Biophys. 1984 Aug 15;233(1):50-63
references.pmid: 6087744
references.citation: Drug Metab Dispos. 2000 Sep;28(9):1107-11
references.pmid: 10950857
references.citation: J Biol Chem. 1990 Apr 15;265(11):6139-45
references.pmid: 2318851
references.citation: Eur J Pharm Sci. 2006 May;28(1-2):51-8
references.pmid: 16488120
references.citation: Arch Biochem Biophys. 1996 Sep 1;333(1):109-16
references.pmid: 8806760
references.citation: Arch Biochem Biophys. 1999 Jul 15;367(2):322-32
references.pmid: 10395751
references.citation: Free Radic Res. 2007 Apr;41(4):489-97
references.pmid: 17454131